Editorial in The Lancet Psychiatry helpfully calls for a “dispassionate analysis of the evidence” about psychiatric medication. It seems to be particularly concerned about what it calls “Hooked on happy pills” headlines that have appeared in British newspapers over recent years (see one example).
By criticising these articles without dealing with the issues, the editorial could be taken as another example of minimising the significance of antidepressant discontinuation problems (see previous post). This issue does need to be taken seriously.
Why doesn’t The Lancet Psychiatry commission a review of the evidence? Or more generally, why doesn’t it commission an analysis of the placebo amplification hypothesis of antidepressant efficacy (see previous post). Rather than platitudes in an editorial, it should be doing its job of analysing the evidence. There are too many issues about psychiatric medication that are being fought out in the press rather than psychiatric journals dealing with these matters scientifically.
Sunday, September 30, 2018
Analysing the evidence about antidepressants and other psychiatric medication
Subscribe to: Post Comments (Atom)
Yes I agree absolutely with this. Am at present as a career struggling to try to advocate for a family member with local services around medication. Have met with denial of withdrawal effects from anti psychotic medication that I see before my eyes.
Post a Comment